Barclays raised the firm’s price target on Colgate-Palmolive to $84 from $82 and keeps an Equal Weight rating on the shares ahead of the Q1 report. In consumer health products and beverages, investors are starting to look beyond the expensive high-visibility names for more value-oriented opportunities, the analyst tells investors in a research note. Meanwhile, in food, the firm wouldn’t be surprised to see more “second derivative” share reactions to Q1 upside versus “admittedly very subdued expectations.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $94 from $89 at Stifel
- Colgate-Palmolive price target raised to $96 from $90 at Evercore ISI
- 5 Best Consumer Staples Stocks to Buy in April 2024, According to Analysts
- Colgate-Palmolive removed from Franchise Picks List at Jefferies
- Buy/Sell: Wall Street’s top 10 stock calls this week
Questions or Comments about the article? Write to editor@tipranks.com